These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 27379550)
1. Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats. Shi LL; Xie H; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Mol Pharm; 2016 Aug; 13(8):2667-76. PubMed ID: 27379550 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
3. Rhodojaponin III-Loaded Chitosan Derivatives-Modified Solid Lipid Nanoparticles for Multimodal Antinociceptive Effects in vivo. Yang Q; Yang J; Sun S; Zhao J; Liang S; Feng Y; Liu M; Zhang J Int J Nanomedicine; 2022; 17():3633-3653. PubMed ID: 35996527 [TBL] [Abstract][Full Text] [Related]
4. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Cho HJ; Park JW; Yoon IS; Kim DD Int J Nanomedicine; 2014; 9():495-504. PubMed ID: 24531717 [TBL] [Abstract][Full Text] [Related]
5. Solid Lipid Nanoparticles and Chitosan-coated Solid Lipid Nanoparticles as Promising Tool for Silybin Delivery: Formulation, Characterization, and In vitro Evaluation. Piazzini V; Cinci L; D'Ambrosio M; Luceri C; Bilia AR; Bergonzi MC Curr Drug Deliv; 2019; 16(2):142-152. PubMed ID: 30306869 [TBL] [Abstract][Full Text] [Related]
6. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology. Chai GH; Xu Y; Chen SQ; Cheng B; Hu FQ; You J; Du YZ; Yuan H ACS Appl Mater Interfaces; 2016 Mar; 8(9):5929-40. PubMed ID: 26860241 [TBL] [Abstract][Full Text] [Related]
7. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies. Patel M; Mundada V; Sawant K Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):144-153. PubMed ID: 30669881 [TBL] [Abstract][Full Text] [Related]
8. Preparation of Deoxycholate-Modified Docetaxel-Cimetidine Complex Chitosan Nanoparticles to Improve Oral Bioavailability. Xu Y; Fang T; Yang Y; Sun L; Shen Q AAPS PharmSciTech; 2019 Sep; 20(7):302. PubMed ID: 31489504 [TBL] [Abstract][Full Text] [Related]
9. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies. Saremi S; Dinarvand R; Kebriaeezadeh A; Ostad SN; Atyabi F Biomed Res Int; 2013; 2013():150478. PubMed ID: 23971023 [TBL] [Abstract][Full Text] [Related]
10. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy. Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854 [TBL] [Abstract][Full Text] [Related]
11. Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport. Liu Y; Jiang Z; Hou X; Xie X; Shi J; Shen J; He Y; Wang Z; Feng N Nanomedicine; 2019 Oct; 21():102075. PubMed ID: 31377378 [TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. Zhao B; Gu S; Du Y; Shen M; Liu X; Shen Y Int J Pharm; 2018 Jan; 535(1-2):164-171. PubMed ID: 29107614 [TBL] [Abstract][Full Text] [Related]
13. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941 [TBL] [Abstract][Full Text] [Related]
14. Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Liu M; Zhong X; Yang Z Sci Rep; 2017 Jan; 7():41322. PubMed ID: 28112262 [TBL] [Abstract][Full Text] [Related]
15. Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer. Chai GH; Hu FQ; Sun J; Du YZ; You J; Yuan H Mol Pharm; 2014 Oct; 11(10):3716-26. PubMed ID: 25197948 [TBL] [Abstract][Full Text] [Related]
16. Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Hu X; Fan W; Yu Z; Lu Y; Qi J; Zhang J; Dong X; Zhao W; Wu W Nanoscale; 2016 Apr; 8(13):7024-35. PubMed ID: 26725649 [TBL] [Abstract][Full Text] [Related]
17. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability. Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336 [TBL] [Abstract][Full Text] [Related]
18. Effect of Surface Charges on Oral Absorption of Intact Solid Lipid Nanoparticles. Yu Z; Fan W; Wang L; Qi J; Lu Y; Wu W Mol Pharm; 2019 Dec; 16(12):5013-5024. PubMed ID: 31638827 [TBL] [Abstract][Full Text] [Related]
19. Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. Chen C; Fan T; Jin Y; Zhou Z; Yang Y; Zhu X; Zhang ZR; Zhang Q; Huang Y Nanomedicine (Lond); 2013 Jul; 8(7):1085-100. PubMed ID: 23075315 [TBL] [Abstract][Full Text] [Related]
20. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake. Xu Q; Zhu T; Yi C; Shen Q Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]